Abstract
Background and Aims: Lipoprotein lipase (LPL) is a key enzyme in triglyceride metabolism and a potential drug target for the treatment of hypertriglyceridemia, a condition shown to be causally related to cardiovascular diseases. LPL is characterized by a broad substrate specificity, which has given rise to a diverse group of methods for determining LPL activity. In this study we compare widely used substrate systems to undiluted human plasma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.